Submit an Article

Navigate

Submit an Article

Online ISSN: 1945-4589

Research Paper|Volume 13, Issue 16|pp. 20661–20683

METTL21B is a prognostic biomarker and potential therapeutic target in low-grade gliomas

Back to articleFigure 9(9 of 9)

−100%+

Figure 9.Construction of prognostic model of METTL21B along with other eEF1A associated methyltransferases. (A) Multivariate Cox model for 5 eEF1A associated methyltransferases and clinical features. (B) The nomogram for METTL21B, EEF1AKMT2, age and WHO grade.